Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ondansetron for Reducing Propofol Injection Pain in Pediatrics
NCT05378113Phase 2Terminated
- Sponsor
- Emory University
- Start
- May 2023
- Primary completion
- Aug 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of ondansetron (2 arms), sponsored by Emory University. Primary endpoints: Verbal Rating Scale and Motor Score Scale. Started May 2023; status: terminated.
02
Drugs
ondansetron
Beyond the preview
Go deeper on NCT05378113.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05378113.